News
10.09.2019
An ERC Proof of Concept Grant has been awarded to IMP Group Leader Johannes Zuber. The funds will be used towards the development of a diagnostic platform for probing drug responses in cancer cells.
06.09.2019
Nabriva Therapeutics Earns $5 Million Milestone Payment under its License Agreement with Sinovant Sciences